Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (8057)	12/14/1998 1:53:00 PM
From: Bluegreen	Respond to of 17367

George, it appears that some people will stoop to anything in order to make a few bucks off of a stock. First he takes posts out of context and then changes them to suit his needs, he reposts them as original without any footnotes or disclaimers! I have never stated Nueprex might not have anti-sepsis effect, I just said focus should be more on antibacterial synergy effects. Just because in one sentence of a post I list anti-sepsis first before synergy with antibiotic doesn't mean I ranked them in importance. Notice where his highlight starts and stops, unbelievable mid-sentence! Tharos had him pegged from the start. Has anybody though really been impressed by his cut and paste with no free hand, thinking on your own analysis? George, you had an excellent point, vast majority of his posts are Xoma related and negative and you are supposed to fall for the line of him having doubts about Xoma that you and Bob need to quell on a constant basis. At least most of us always remind people of risks and that we are just posting opinions. Give me a break! Once again, Tharos had this guy's number from the start.